NeuroMetrix To Debut Wearable Pain Therapy Device At CES

Taking care of oneself is getting a further boost as home health care products are developed with new technologies. According to NeuroMetrix, Quell, the company’s new wearable health device, may provide consumers with chronic pain the relief they seek without a prescription.

Making its debut at the 2015 CES show next week, Quell utilizes non-invasive neurostimulation technology to ease the symptoms of painful conditions such as diabetes, sciatica, fibromyalgia and degenerative knee conditions, according to the company.

The lightweight device can be worn during the day, while a user is active and at night, while asleep. It can also be synced to a smartphone, so that the user can track and personalize his or her use of the Quell.

Shai N. Gozani, M.D., Ph.D, president and CEO of NeuroMetrix, said that recent studies suggest that chronic nerve pain dramatically reduces the quality of life for diabetes patients and that the Quell may help improve their situation. Gozani will offer further insight into such research during the CES Digital Health Summit panel, “Winning the War on Diabetes,” being held on January 8 at 1:15 pm. 

Cleared by the FDA, the company noted, the device is scheduled to be available to consumers in the second quarter of 2015. NeuroMetrix will demo the Quell in the Digital Health section at CES, being held January 6-9 in Las Vegas.